 |
 |
 |
 |
 |
 |
 |
 |
 |
  
|
 |
 |
 |
 |
 |
 |
1-800-220-LAW1
Eleven Penn Center
1835 Market Street
Suite 2600
Philadelphia, PA 19103
Parke-Davis' Rezulin Linked By FDA to 28 Deaths
The FDA has advised
that diabetes drug Rezulin, manufactured by Parke-Davis, only be used
as a last resort for diabetes, because it has been linked to 28 deaths
and serious liver damage. Rezulin's generic name is troglitazone. It has
been used to treat type 2 diabetes (non-insulin dependent or "adult onset"
diabetes).
If you are taking Rezulin, make sure your doctor is carefully and frequently monitoring your liver function with tests, and discuss this new information with your doctor, who has probably already received a letter from Parke-Davis about the use of Rezulin. If you or someone close to you has been affected by this drug, Monheit, Silverman & Fodera, P.C. stands ready to assist you.
This informational piece was prepared by Monheit, Silverman & Fodera. If you would like more information on this topic, call us at (800) 220-LAW1, or use the "Do I Have A Case?" button on this web site.
Medical Malpractice | Medical Devices | Consumer Fraud | Toxic Exposures | Defective Products | Dangerous Pharmaceuticals | Worksite Accidents | Automobile Accidents | Class Actions | Site Directory | Attorney Profiles | Practice Groups
Do I Have A Case? | Verdicts & Settlements | Links | Site Search | Disclaimer | Home
